Financiere des Professionnels - Fonds d'investissement inc.
Position in GILD — Gilead Sciences, Inc.
CIK 1996846
MONTREAL, A8
Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,354,724
+$2,187,480 QoQ
Shares Held
18,638
+1453.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#786
of 2,266 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financiere des Professionnels - Fonds d'investissement inc. holds $56,644,054 across 7 Drug Manufacturers - General names. GILD ranks #6 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
58,412 | $14,698,795 | |
| 2 | JNJ |
Johnson & Johnson
|
51,324 | $13,034,755 | |
| 3 | MRK |
Merck & Co., Inc.
|
93,117 | $11,965,534 | |
| 4 | LLY |
ELI LILLY & Co
|
7,894 | $9,468,301 | |
| 5 | PFE |
Pfizer Inc
|
201,100 | $4,842,488 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
18,638 | $2,354,724 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,850 | $279,457 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,354,724 | 18,638 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $167,244 | 1,200 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $4,584,339 | 37,350 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $3,657,228 | 32,948 | Shares | Defined | 2025-10-21 | |
| 2025-06-30 | $3,652,944 | 32,948 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $112,050 | 1,000 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $221,688 | 2,400 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $201,216 | 2,400 | Shares | Sole | 2024-10-31 | |
| No filing history on record for this holder in this stock. | ||||||